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1. Introduction 
In most tissues, the metabolism of exogenous 
adenosine is initiated by either adenosine kinase 
(EC 2.7 .1.20) or adenosine deaminase (EC 3 5.4.4) 
activities. A general finding is that phosphorylation of 
adenosine is favored at low adenosine concentrations 
while deamination is favored at higher concentrations 
[l-4]. Several workers have suggested that this 
concentration-dependent metabolic fate of adenosine 
arises from the compartmentation of adenosine 
kinase activity adjacent to the membrane transport 
system for adenosine [5-71. In contrast, results 
obtained with human red cells incubated in the 
presence and absence of the nucleoside transport 
inhibitor p-nitrobenzylthioguanosine (2-amino-6 
[(4-nitrobenzyl)thio]-9$3-D-ribofuranosylpurine) 
led Agarwal and Parks to conclude that adenosine 
deaminase activity may be closely associated with 
the nucleoside transporter on the red cell membrane 
[8]. The simple experiments reported here do not 
support these hypotheses of compartmentation of 
either adenosine kinase or adenosine deaminase in 
human red cells. Rather, our results indicate that the 
metabolic fate of adenosine in these cells is influ- 
enced mainly by the maximal activity and Km param- 
eters for adenosine kinase and adenosine deaminase. 
2. Materials and methods 
2.1. General 
Details of most of the materials and methods used 
in this study have been described in [9]. All experi- 
ments were performed with washed human erythro- 
cytes (20% hematocrit) in Krebs-Ringer medium 
containing 25 mM phosphate [9]. 
2.2. Metabolism of [8-‘4C’adenosine 
Cells were incubated for 80-90 min in the 
Krebs-Ringer phosphate medium to allow the 
intracellular phosphate concentration to reach a steady 
state level of about 7-8 mM [lo]. [8-14C] Adenosine 
(Radiochemical Centre, Amersham; 5 Ci/mol) was 
then added to give the required concentration. In 
experiments where nucleoside transport inhibitors 
were used, these were added to a final concentration 
of 10 I.IM 10 min prior to the addition of the [8-14C]- 
adenosine. 
2.3. Extraction of purines and chromatography 
Samples of erythrocytes were extracted with 
HC104, the extracts neutralised and the purines sepa- 
rated by thin-layer chromatography on PEI-cellulose 
(Macherey-Nagel) as described in [9]. 
2.4. Quantification of adenosine metabolised via 
adenosine kinase and adenosine deaminase 
The [8-14C] adenosine incorporated into the vari- 
ous purineswas quantified by liquid scintillation 
counting [ 91. Because adenylosuccinate synthetase 
(EC 6.3.4.4) activity is absent from mature human 
red cells [ 11,121 and AMP deaminase (EC 3.5.4.6) 
activity is strongly inhibited in situ under these exper- 
imental conditions [9], the metabolism of adenosine 
in these cells is limited to the pathways shown in 
fig.1. Therefore, the amount of the [8-14C]adenosine 
which is metabolised via the kinase reaction is given 
by the sum of counts accumulated in AMP, ADP and 
ATP, while the amount of adenosine metabolised via 
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Fig.1. Metabolism of adenosine in human erythrocytes. The 
enzymes indicated are: 1, adenosine kinase; 2, adenosine 
deaminase. 
the deaminase reaction is given by the sum of counts 
accumulated in inosine, hypoxanthine and IMP. In 
the high phosphate medium used in this study, the 
bulk of the counts were recovered in ATP and IMP. 
3. Results and discussion 
3.1. The metabolism of adenosine in the presence and 
absence of nucleoside transport inhibitors 
Of a single dose of 50 pM [S-14C] adenosine, -80% 
was metabolised via the adenosine deaminase reaction 
while the remaining 20% was incorporated into 
adenine nucleotides (fig.2A). Under these conditions, 
all of the adenosine was utilised within 5 min and the 
end-products of the metabolism (mainly IMP and 
ATP) were stable for at least 30 min (fig.2A). How- 
ever, when this experiment was performed in the 
presence of 10 PM p-nitrobenzylthioguanosine, the 
metabolism of adenosine was considerably slower and 
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Fig.2. Metabolism of 50 MM adenosine in the absence (A) and 
presence (B) of 10 PM p-nitrobenzylthioguanosine. 0,adeno- 
sine deaminated; o, adenosine phosphorylated. 
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were adenine nucleotides (fig.2B). Essentially iden- 
tical results were obtained when 10 pM Persantin@ 
(dipyridamole, Boehringer Ingelheim Ltd) was used 
to inhibit nucleoside transport. Since 10 PM concen- 
trations of these inhibitors prevent uptake of nucleo- 
sides via the nucleoside transporter [8,13], the aden- 
osine which entered the cells in this experiment must 
have done so by passive diffusion through the cell 
membrane. This very slow passive diffusion would 
result in a lower intracellular concentration of adeno- 
sine. Further, the intracellular metabolism of aden- 
osine is not affected directly by the presence of 
transport inhibitor as p-nitrobenzylthioguanosine 
does not affect adenosine deaminase activity [8] and 
we have determined that it does not affect adenosine 
kinase activity either. 
There are two possible interpretations of these 
results. The adenosine kinase may be located at sites 
on the membrane which allow passive diffusion of 
adenosine (conversely, adenosine deaminase may be 
located adjacent to the nucleoside transporter as 
suggested by Agarwal and Parks [S]). Alternatively, 
the factors which determine the metabolic fate of 
adenosine are independent of the location of the 
kinase and deaminase but depend instead on the 
kinetic parameters of these two enzymes. Results 
which differentiate between these two possibilities 
are presented below. 
3.2. Effect of adenosine concentration on its 
metabolic fate 
The metabolic fate of 5 PM, 10 pM and 50 pM 
adenosine is shown in fig.3. To ensure that sufficient 
counts were incorporated into the various purine 
metabolites to allow for their accurate estimation, 
5 PM ‘pulses’ of adenosine were added to incuba- 
tion A at 3-min intervals for a total of 10 ‘pulses’. 
Similarly, in incubation B, 5 ‘pulses’ each of 10 FM 
adenosine were added at 6-min intervals while incu- 
bation C received a single ‘pulse’ of 50 pM adenosine. 
In this way the same total number of counts was 
added to each incubation [lo]. The results show 
clearly that phosphorylation of adenosine was favoured 
at the 5 pM concentration while deamination of 
adenosine predominated at the 50 pM concentration. 
Since no transport inhibitor was present in this exper- 
iment, the bulk of the adenosine would have entered 
the cells via the nucleoside transport system in all 
three incubations. Therefore, the mode of entry of 
adenosine into the erythrocyte did not play a signifi- 
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Fig.3. Proportions of adenosine phosphorylated and deami- 
nated at different adenosine concentations. Adenosine was 
added as follows: (A) 10 ‘pulses’ of 5 rM each at 3-min 
intervals, (B) 5 ‘pulses’ of 10 irM each at 6-min intervals; 
(C) 1 ‘pulse’ of 50 FM adenosine. Duplicate samples were 
taken for extraction and analysis from each incubation 
35 mm after the addition of the first ‘pulse’. The hatched 
bars represent he amount of adenosine phosphorylated while 
the open bars represent he amount of adenosine deaminated. 
cant role in dete~ining its metabolic fate. Rather, 
the concentration of adenosine entering the cells 
appeared to be the more important factor deter- 
mining the proportions of adenosine phosphorylated 
and deaminated. 
Our results argue against the compartmentation of 
either adenosine kinase or adenosine deaminase in 
human erythrocytes. Indeed, all of our data can be 
interpreted in terms of the maximal activity and 
Km parameters for these two enzymes. Adenosine 
deaminase maximal activity in human erythrocytes 
is 200-400 nmol/min~ml packed ceils [ 141 and the 
enzyme exhibits a Km for adenosine of 30 PM [ 151. 
The adenosine kinase maximal activity is -40 nmol/ 
FEBS LETTERS May 1980 
mm/ml packed cells and the Km for adenosine is 
0.7 PM [ 161. From these values, it may be calculated 
that phosphorylation of adenosine is favoured at the 
5 PM concentration while deamination would pre- 
dominate at the 50 E.~M concentration. 
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